Abstract
In considering the therapeutics of cardiac conditions in children, one is rather surprised to find that therapeutic measures have either been handed down or accepted simply from pharmacological experimentation, which is not always an accurate estimate of the clinical value of any therapeutic procedure or of any drug. It is interesting to note the paucity of material which deals with accurate observations of the different drugs used in cardiac conditions. Practically all of the English text-books speak of digitalis and strychnin as the two cardiac stimulants of choice. Digitalis has been tested out both experimentally and clinically, so that there can be very little doubt as to its value. In regard to strychnin, there is conflicting evidence from the side of the pharmacologist and that of the clinician. It is still further interesting to note that in none of the German text-books is strychnin mentioned, and it is very seldom
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
